We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

News   Jan 24, 2018 | Original story from Cobra Biologics

 
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK

Peter Coleman, CEO Cobra Biologics

 
 
 

RELATED ARTICLES

Century-long Puzzle (Dis)solved About Protein Crystals in Asthma

News

Charcot-Leyden Crystals are made from the protein Galectin-10 and were discovered in the airways of asthmatics as early as 1853. However, the crystals have been largely ignored by scientists, and their actual link to disease remained unknown, until now.

READ MORE

New Exercise Guidelines for Cancer Patients

News

A decade-old treatment recommendation for people with cancer to take a "slowly slowly" approach to exercise has been replaced with new guidelines recommending a personalized exercise program.

READ MORE

Are Transplanted Stem Cells Healing the Target Organ? Perhaps Ask the Exosomes

News

While many regenerative medicine applications are being pursued, the ability to track cells after transplant and determine their therapeutic efficacy is a challenge. Could exosomes, circulating cell-derived vesicles, hold the key?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE